Skip to main content

Amalgamated Bank

SEC CIK
0000919192
Latest filing
Jul 23, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
108,443
Value
$9.81M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Amalgamated Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026108,443$9.81M0.1%+214+0.2%AddedHolders
Q1 2026108,229$8.67M0.1%−2,778−2.5%ReducedHolders
Q4 2025111,007$9.46M0.1%−460−0.4%ReducedHolders
Q3 2025111,467$8.67M0.1%−1,857−1.6%ReducedHolders
Q2 2025113,324$8.86M0.1%−5,581−4.7%ReducedHolders
Q1 2025118,905$8.62M0.1%+399+0.3%AddedHolders
Q4 2024118,506$8.77M0.1%−1,248−1.0%ReducedHolders
Q3 2024119,754$7.90M0.1%−3,367−2.7%ReducedHolders
Q2 2024123,121$11.4M0.1%−7,600−5.8%ReducedHolders
Q1 2024130,721$12.5M0.1%−20,649−13.6%ReducedHolders
Q4 2023151,370$11.5M0.1%−10,327−6.4%ReducedHolders
Q3 2023161,697$11.2M0.1%−13,480−7.7%ReducedHolders
Q2 2023175,177$16.5M0.1%+7,604+4.5%AddedHolders
Q1 2023167,573$13.9M0.1%−809−0.5%ReducedHolders
Q4 2022168,382$12.6M0.1%−2,651−1.5%ReducedHolders
Q3 2022171,033$14.1M0.1%+5,805+3.5%AddedHolders
Q2 2022165,228$15.7M0.1%−9,895−5.7%ReducedHolders
Q1 2022175,123$20.6M0.2%+7,137+4.2%AddedHolders
Q4 2021167,986$21.8M0.2%+28,573+20.5%AddedHolders
Q3 2021139,413$15.8M0.1%−6,348−4.4%ReducedHolders
Q2 2021145,761$15.1M0.1%+107,749+283.5%AddedHolders
Q1 202138,012$3.18M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.